Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A new, pluronic-based, bone hemostatic agent that does not impair osteogenesis.

M Y Wang1, J K Armstrong, T C Fisher

  • 1Division of Neurosurgery, Childrens Hospital of Los Angeles, 1200 NorthState Street, Los Angeles, CA 90033, USA. myw@hsc.usc.edu

Neurosurgery
|September 21, 2001
PubMed
Summary

A novel Pluronic copolymer blend effectively stops bone bleeding without hindering bone healing, unlike traditional bone wax. This absorbable hemostatic agent shows promise for critical bone fusion sites.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Comparing traditional modeling approaches versus predictive analytics methods for predicting multiple sclerosis relapse.

Multiple sclerosis and related disorders·2022
Same author

Blistering severe cutaneous adverse reactions in children: proposal for paediatric-focused clinical criteria.

The British journal of dermatology·2021
Same author

Consensus, collaboration and care coordination.

The British journal of dermatology·2019
Same author

The Effect of Hemorheologic Factors on Middle Cerebral Artery Blood Flow Velocity in Young Individuals.

Journal of neuroimaging : official journal of the American Society of Neuroimaging·2016
Same author

Nimodipine and the evolution of hemorheological variables after acute ischemic stroke.

Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association·2015
Same author

Survivin as a therapeutic target in Sonic hedgehog-driven medulloblastoma.

Oncogene·2014

Area of Science:

  • Biomaterials Science
  • Orthopedic Surgery
  • Regenerative Medicine

Background:

  • Surgical beeswax (bone wax) is used for intraoperative bone hemostasis.
  • Bone wax impedes osteogenesis, making it unsuitable for procedures requiring bone fusion.

Purpose of the Study:

  • To evaluate a Pluronic copolymer blend as a biocompatible, absorbable hemostatic agent for bone.
  • To compare the effects of Pluronic blend and bone wax on bone regeneration in vivo.

Main Methods:

  • Rat femur defect and nonunion models were utilized.
  • Animals were divided into bone wax, Pluronic blend, and control groups.
  • Radiographic and histological analyses were performed at multiple time points.

Main Results:

Related Experiment Videos

  • Pluronic blend did not inhibit bone formation in defect models.
  • Osseous callus formation was observed in Pluronic-treated and control groups in nonunion models.
  • Bone wax significantly inhibited bone growth in both models.

Conclusions:

  • The Pluronic blend offers comparable handling and hemostasis to bone wax without inhibiting bone regrowth.
  • Pluronic compounds are effective absorbable hemostatic agents for critical bone fusion sites.
  • This copolymer blend may also serve as a drug delivery vehicle to enhance fusion rates and reduce complications.